Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1999
09/02/1999WO1999043657A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
09/02/1999WO1999043654A2 Inhibitors of phospholipase enzymes
09/02/1999WO1999043653A1 Synthesis of epothilones, intermediates thereto and analogues therof
09/02/1999WO1999043652A1 Indole derivatives and medicinal compositions containing the same
09/02/1999WO1999043651A2 Inhibitors of phospholipase enzymes
09/02/1999WO1999043648A1 Cyclic amino compounds
09/02/1999WO1999043646A1 Cyclohexanediole derivatives
09/02/1999WO1999043642A1 Phenylalanine derivatives as inhibitors of alpha4 integrins
09/02/1999WO1999043636A2 Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
09/02/1999WO1999043426A1 Matrix for preparing microparticles or nanoparticles, method for making said particles and resulting particles
09/02/1999WO1999043358A1 Dendrimeric fullerene derivatives, method for producing same and their use as neuroprotectors
09/02/1999WO1999043355A2 Formulations containing oxaliplatin
09/02/1999WO1999043354A2 Method for treating painful conditions of the anal region and compositions therefor
09/02/1999WO1999043343A1 Novel peptide copolymer compositions
09/02/1999WO1999043336A1 L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
09/02/1999WO1999043334A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
09/02/1999WO1999043333A1 Therapeutic and prophylactic uses of negatively charged substituted disaccharides
09/02/1999WO1999043332A1 Antitumor combination comprising epirubicin and gemcitabine for the treatment of non-small-cell lung cancer
09/02/1999WO1999043331A1 Acetylsalicyclic acid and folic acid for decoagulating blood platelets
09/02/1999WO1999043330A1 Langerhans cell migration inhibitors
09/02/1999WO1999043328A1 Treatment of hiv infections
09/02/1999WO1999043327A1 Antimicrobial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith
09/02/1999WO1999043326A1 Use of a cardiac purinoceptor to effect cellular glucose uptake
09/02/1999WO1999043325A1 Preventives or remedies for diseases in association with vascular functional anomaly relating to insulin resistance
09/02/1999WO1999043324A1 Preventives or remedies for drug-induced renal disturbance
09/02/1999WO1999043323A1 Compounds and methods for chemosensitizing multidrug resistant cells
09/02/1999WO1999043322A1 Method for the treatment of pain, including chronic and female specific pain
09/02/1999WO1999043321A1 Interstitial adenosine level-elevating agents
09/02/1999WO1999043320A1 Use of epothilones for the treatment of cancer
09/02/1999WO1999043319A1 Agents with serotonin-related activity for the treatment for sleep apnea
09/02/1999WO1999043317A1 Necrosis-affine compounds and the utilization thereof in order to produce preparations for pharmacotherapy
09/02/1999WO1999043314A1 Farnesyl-protein transferase inhibitors
09/02/1999WO1999043310A2 20-hete antagonists and agonists
09/02/1999WO1999043309A2 Anticonvulsant drugs and pharmaceutical compositions thereof
09/02/1999WO1999043308A2 Treating pulmonary hypertension through tenascin suppression and elastase inhibition
09/02/1999WO1999043307A1 Thyroid hormone replacement using sustained release triiodothyronine
09/02/1999WO1999043305A1 Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents
09/02/1999WO1999043304A1 Stable shaped particles of crystalline organic compounds
09/02/1999WO1999043303A1 Method for producing encased spherical granular grains
09/02/1999WO1999043300A1 Butorphanol sustained release formulations
09/02/1999WO1999043285A2 Sulphonamide derivatives
09/02/1999WO1999043220A1 Product and method to reduce stress induced immune suppression
09/02/1999WO1999043218A1 Method for producing a fat mixture
09/02/1999WO1999043217A1 Use of d-tagatose as a prebiotic food component
09/02/1999WO1999043210A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist
09/02/1999WO1999043208A1 The helios gene
09/02/1999WO1999033958A3 Desaturase
09/02/1999WO1999033841A3 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
09/02/1999WO1999033521A3 Use of chelating agents in the treatment of atherosclerotic conditions
09/02/1999WO1999033450A3 Pharmaceutical composition containing sibutramine and orlistat
09/02/1999WO1999033434A3 Use of inorganic-organic hybrid prepolymers
09/02/1999WO1999032097A3 Phytosterol composition for preventing alzheimer's disease
09/02/1999WO1999032085A3 Novel pharmaceutical compositions of uridine triphosphate
09/02/1999WO1999030720A8 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
09/02/1999WO1999030693A3 A double capsule for the administration of active principles in multiple therapies
09/02/1999WO1999026632A8 Phospholipids having antimicrobial activity with or without the presence of antimicrobials
09/02/1999WO1999025716A9 Pyranones, method for the production and use thereof
09/02/1999WO1999024460A3 Dipeptide nitriles
09/02/1999WO1999023105A9 Vegi, an inhibitor of angiogenesis and tumor growth
09/02/1999WO1999021540A3 Method of reducing craving in mammals
09/02/1999WO1999006009A3 THERAPEUTIC PROCESS FOR INHIBITING NF-λB
09/02/1999WO1998040052A9 Cationic lipid compositions targeting angiogenic endothelial cells
09/02/1999WO1998034632A9 Compounds and compositions for delivering active agents
09/02/1999DE19806853A1 Verfahren zur Herstellung von Polymeren aus N-Vinylverbindungen A process for preparing polymers of N-vinyl compounds
09/02/1999CA2322167A1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
09/02/1999CA2322163A1 Inhibitors of phospholipase a2
09/02/1999CA2322162A1 Inhibitors of phospholipase enzymes
09/02/1999CA2322161A1 Inhibitors of phospholipase enzymes
09/02/1999CA2322139A1 Sulphonamide derivatives
09/02/1999CA2321993A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
09/02/1999CA2321991A1 Method for the treatment of pain, including chronic and female specific pain
09/02/1999CA2321970A1 36 human secreted proteins
09/02/1999CA2321924A1 Butorphanol sustained release formulations
09/02/1999CA2321869A1 Human proteinase molecules
09/02/1999CA2321830A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
09/02/1999CA2321719A1 Farnesyl-protein transferase inhibitors
09/02/1999CA2321642A1 N-¬(substituted five-membered di- or triaza diunsaturated ring)carbonyl|guanidine derivatives for the treatment of ischemia
09/02/1999CA2321565A1 L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
09/02/1999CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
09/02/1999CA2321528A1 Substance having steroid-like structure, method for preparation therof and antitumor agent containing
09/02/1999CA2321307A1 Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs
09/02/1999CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy
09/02/1999CA2320829A1 Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics
09/02/1999CA2320764A1 Treatment of hiv infections
09/02/1999CA2320289A1 Novel peptide copolymer compositions
09/02/1999CA2319752A1 Use of epothilones for the treatment of cancer
09/02/1999CA2318778A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist
09/02/1999CA2318762A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
09/02/1999CA2317416A1 Substituted 1,2,4-triazolo¬3,4-a|pyridazine
09/01/1999EP0939131A2 Aminopeptidases
09/01/1999EP0939124A2 MGBP1 sequences
09/01/1999EP0939123A2 Estrogen receptor-related polypetide SBPERR4
09/01/1999EP0939077A2 3-Substituted 1-arylindole compounds as 5-HT2 antagonists
09/01/1999EP0938900A1 Preventives/remedies for stomatitis
09/01/1999EP0938899A2 Agent for improving the blood circulation
09/01/1999EP0938898A2 Treatment of pruritus
09/01/1999EP0938897A1 Telomerase inhibitor
09/01/1999EP0938896A1 Autoclavable pharmaceutical compositions containing a chelating agent
09/01/1999EP0938895A1 New composition to be delivered to the rhinopharyngeal mucose, particularly pernasal
09/01/1999EP0938891A1 Cosmetic composition containing cinnamic acid or its derivatives and its use